Jennifer Quint is a Professor of Respiratory Epidemiology at the National Heart and Lung Institute and Honorary Consultant Physician in Respiratory Medicine at the Royal Brompton and Imperial College London NHS Foundation Trusts.
Dr Quint’s research interests centre on the use of electronic health records to study chronic obstructive pulmonary disease (COPD) as well as other chronic respiratory diseases including asthma, ILD and bronchiectasis. She leads a clinical epidemiology research group whose work centres largely on understanding the relationship between cardiovascular and respiratory disease as well as maximising the quality, linkage and usage of routinely collected data for clinical and research purposes. The majority of her work has been on exacerbations of COPD, exploring both the effect of COPD exacerbations on vascular outcomes and the relationship between environmental factors and exacerbations of COPD.
et al., 2021, Chronic Obstructive Pulmonary Disease (COPD) in population studies in Russia and Norway: Comparison of prevalence, awareness and management, International Journal of Copd, ISSN:1176-9106
et al., 2021, Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial, International Journal of Copd, ISSN:1176-9106
et al., 2021, Effectiveness and Safety of COPD Maintenance Therapy with a LAMA/LABA versus LABA/ICS in a US Claims Database, Advances in Therapy, ISSN:0741-238X
et al., 2021, UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records, Bmc Public Health, Vol:21
et al., 2021, Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients, European Respiratory Journal, Vol:57, ISSN:0903-1936